AnalystsCatherine NovackCatherine Novack's Stock Forecasts
AnalystsCatherine Novack
Analyst Ranking
Bottom 12%
#4325 out of 4870 analysts
Average Return
-9.25%
Win Rate
17%3 out of 18
Risk vs Reward
Poor
Good
Catherine Novack's 5 best and worst ratings
Catherine Novack Analyst Color
Get additional color on Catherine Novack's coverage of popular stocks
Catherine Novack's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regulus Therapeutics IncRGLS | 2 | Hold | $7.00 | -10.83% | Downgrades | 2 days ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $45.00 | +86.80% | Initiates Coverage On | a month ago |
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $11.00 | +539.53% | Initiates Coverage On | 3 months ago |
Korro Bio IncKRRO | 1 | Strong Buy | $130.00 | +606.71% | Initiates Coverage On | 5 months ago |
Capricor Therapeutics IncCAPR | 1 | Strong Buy | $40.00 | +213.97% | Initiates Coverage On | 5 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $16.00 | +101.51% | Maintains | 7 months ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $14.00 | +389.51% | Initiates Coverage On | 8 months ago |
Dare Bioscience IncDARE | 2 | Strong Buy | $13.00 | +343.69% | Maintains | 9 months ago |
Rezolute IncRZLT | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Femasys IncFEMY | 1 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Calcimedica IncCALC | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 2 years ago |
Omega Therapeutics IncOMGAQ | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Decibel Therapeutics IncDBTX | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Kezar Life Sciences IncKZR | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.